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Introduction
Neo-adjuvant chemotherapy (NAC) has revolutionized 
the care for patients with operable and inoperable breast 
cancers. It has helped to reduce the mortality and improve 
the surgical options in terms of making inoperable tumors 
excisable and conversion to breast conservation in operable 
breasts and early collection of information on the treatment 
response and tumor biology of breast cancer (Kaufmann 
et al., 2007; Youn et al., 2015). Published studies have 
demonstrated a significant clinical response rate of the 
primary tumor to neo-adjuvant chemotherapy with success 
rates of 80% to 90% (Abdel-Razeq et al., 2011; Lobbes et 
al., 2013). At times, a complete clinical, radiological and 
pathological response can be achieved after neoadjuvant 
therapy, but the results vary widely (6-33%) (Abdel-Razeq 
et al., 2011; Lobbes et al., 2013). Although a pathological 
complete response is aimed and is associated with good 
prognosis, a complete clinical and radiological response 
is associated with difficulty for breast surgeon to identify 
the exact area for excision corresponding to primary tumor 
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Abstract
 Background: To determine the outcome and cost saving by placing ultrasound guided surgical clips for tumor 
localization in patients undergoing neo-adjuvant chemotherapy for breast cancer. Materials and Methods: This 
retrospective cross sectional analytical study was conducted at the Department of Diagnostic Radiology, Aga Khan 
University Hospital, Karachi, Pakistan from January to December 2014. A sample of 25 women fulfilling our 
selection criteria was taken. All patients came to our department for ultrasound guided core biopsy of suspicious 
breast lesions and clip placement in the index lesion prior to neo-adjuvant chemotherapy. All the selected patients 
had biopsy proven breast cancer. Results: The mean age was 45 ± 11.6 years. There were no complications seen 
after clip placement in terms of clip migration or hemorrhage. The cost of commercially available markers was 
approximately PKR 9,000 (US$ 90) and that of the surgical clip was PKR 900 (US$ 9). The cost of surgical clips 
in 25 patients was PKR 22,500 (US$ 225), when compared to the commercially available markers which may 
have incurred a cost of PKR 225,000 (US$ 2,250). The total cost saving for 25 patients was PKR 202,500 (US$ 
2, 025), making it PKR 8100 (US$ 81) per patient. Conclusions: The results of our study show that ultrasound 
guided surgical clip placement in index lesions prior to neo-adjuvant therapy is a safe and cost effective method 
to identify tumor bed and response to treatment for further management. 
Keywords: Breast cancer - neo adjuvant chemotherapy - biopsy - surgical clip marker
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bed. To avoid this complication, use of radiopaque markers 
for the identification of primary tumors after neo-adjuvant 
chemotherapy has long been used worldwide and has been 
reported as a safe technique for localization of tumor bed 
for surgical excision after neo-adjuvant chemotherapy, 
particularly with a complete clinical and radiological 
response (Oh ., 2007; Kaufmann et al., 2012; Youn et al., 
2015). In a study by (Dash et al., 1999) all the patients 
(n=28) underwent clip placement and preoperative 
chemotherapy and the study concluded that in 35.7% of 
patients, it would have been impossible and in 21.4% 
difficult to do wire localizations without clip placement. 
They reported that clip placement prior to neo-adjuvant 
chemotherapy was valuable in 57% of patients at the time 
of needle localization.
In another study (Edeiken et al., 1999), the metallic 
markers were the only remaining evidence of original 
tumor site in 47% (23 out of 49) of patients. In this 
study, all metallic markers were placed under ultrasound 
guidance in an assumption that tumor will show complete 
or near complete response to neo-adjuvant therapy. This 
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study reported that radio opaque marker placement prior 
to neo-adjuvant chemotherapy addresses the problem of 
preoperative tumor bed localization in patients who are 
expected to achieve a complete or near complete response.
In most parts of the world, commercially available 
titanium based clips are used for tumor bed localization. 
These are placed within the tumor with the help 
of radiological assistance such as ultrasound and 
mammography (Margolin et al., 2003). Many other 
studies conducted in west support the use of radiopaque 
clip placement preoperatively for tumor bed localization 
before neo-adjuvant chemotherapy. The cost of such clips 
varies from between PKR 9,000 to 15,000 (US$ 90 to 
150) depending upon make and visibility options. Use of 
such radiopaque markers in patients belonging to third 
world countries, where the entire treatment expenses are 
borne by the patients, can add a substantial cost burden. 
Therefore, instead of using the expensive commercially 
available markers, we utilized the standard titanium 
surgical clips, also known as ligaclips used in various 
breast surgeries, as our radiopaque marker. These clips 
can be placed easily by a 16G spinal needle, without the 
need for commercially available applicator. These clips 
are easily available, cost effective (PKR 900, US$ 9), 
Magnetic Resonance Imaging (MRI) compatible and 
no complications have been reported after their use. 
Therefore, the purpose of this study was to review the cost 
effectiveness of these surgical clips in terms of tumor bed 
localization and any possible complications encountered 
during or after clip placement, such as clip migration, 
bleeding, infection and pain.
Materials and Methods
It was a retrospective analytical study, conducted at 
radiology department of Aga Khan University hospital. 
The study duration was from January to December 2014. 
Convenience sampling was used. Exemption was granted 
from Ethical Review Committee of Aga Khan University 
Hospital (ERC # 3594-Rad-ERC-15).
 
Informed consent
All patients had consented to the placement of ligaclip 
within the tumor bed after core biopsy and had signed the 
pre-designed hospital consent form. They were counseled 
in detail by the primary surgeon as well as the radiologist 
before the performance of procedure about the nature of 
ligaclip, the method and purpose of placement and the 
rare possibility of clip migration as well as associated 
complications.
Inclusion criteria
All female patients who had a histopathological 
diagnosis of breast cancer on core needle biopsy and were 
to undergo neo-adjuvant chemotherapy for reduction in 
tumor size were included in the study.
All patients who had their mammograms, ultrasound 
and core biopsy and guided clip placement followed by 
surgery at our institution were included in the study.
Exclusion criteria
Patients with incomplete medical records or who had 
surgery outside our institution were excluded.
Patients with Stage IV disease and those who showed 
progression of disease during or after chemotherapy were 
also excluded.
Clip placement technique
All breast biopsies and subsequent clip placements 
were performed by radiologist with 5 to 10 year experience 
in breast imaging using ultrasound guidance. 
All patients initially underwent ultrasound guided 
core biopsy of index lesion using a 14G needle with an 
automated gun, at least 4 to 5 cores were taken (Figure 
1). This was followed by placement of a surgical clip in 
the index lesion using a 16G spinal needle. The surgical 
clip was closed by an applicator for its easy passage 
through the bore of 16G needle. The stylet of 16G spinal 
needle was used to advance the clip through the bore of 
spinal needle into the center of lesion using ultrasound 
guidance. Following successful placement of clips, two 
mammographic views were performed in craniocaudal 
(Figure 2) and mediolateral projection to ascertain the 
correct position of clip within the lesion before discharging 
the patient.
Following neo-adjuvant chemotherapy, the 
mammograms were repeated to see the response of the 
index lesion (Figure 3). In case of complete clinical and 
radiological response, if breast conservation was to be 
performed, the patient underwent bracketing (Figure 4) 
or needle localization of surgical clip (Figure 5) under 
mammographic guidance prior to definitive surgery. The 
excised specimen was subjected to specimen radiography 
to ascertain that the targeted area has been removed 
with satisfaction (Figure 6). In case of mastectomy, no 
bracketing or needle localization was performed.
All mammogram and ultrasound images were 
reviewed by two experienced radiologists with 5 to 10 
years of experience in breast imaging. All images of 
pre and post ligaclip placement and post neo-adjuvant 
chemotherapy were reviewed for correct clip placement, 
and possible complications such as clip migration. Medical 
record files of all patients were also seen for any possible 
complaints after ligaclip insertion on their follow up visit 
in breast clinic.
Data analysis
Information was extracted retrospectively from the 
hospital’s computerized database and analysis was done 
using SPSS version 20. Frequencies and means were 
calculated. The percentage of complications was also 
recorded. The cost effectiveness was determined by 
calculating the cost of ligaclip and commercially available 
metallic markers for  25 patients in Pakistani rupees and 
US dollars, the cost was also determined for individual 
patient. The two figures were subtracted to get the cost 
saving.
Results 
From January 2014 to December 2014, 350 patients 
underwent ultrasound guided core biopsy of breast 
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lesions at our institute. Out of these 192 biopsies were 
malignant and 158 were benign on histopathology. All 
patients with bilateral breast procedures were taken as n= 
2. A total of 192 cases had ligaclips placed within their 
lesions at the time of core biopsy. Out of 192, only 25 
patients fulfilled our selection criteria i.e. biopsy proven 
malignant disease of breast with ligaclip in index lesion, 
non-metastatic disease, having received NAC followed by 
surgery (mastectomy or breast conservation) and available 
pre and post neo-adjuvant mammograms with ligaclip 
visible in them. Ligaclip in all cases were placed with a 
uniform method prior to initiation of NAC. All patients 
with benign lesions, incomplete records and progression 
of disease during or after chemotherapy were excluded 
from this study. The procedures of ligaclip placement as 
well as definitive surgery for all the included cases were 
performed at our institute only. The mean age of patients 
was 45 ± 11.6years. One to 3 ligaclips were placed in a 
single lesion. The duration of chemotherapy was from 75 to 
200 days. Out of 25 lesions, 15 were in right breast and 10 
in the left breast. Maximum number (n=10) of lesions were 
in upper outer quadrant. Out of 25 clips 23 were within the 
index lesion, two of them were 1 to 2 mm anterior to the 
lesion. There was no migration of clips on post procedure 
mammograms and subsequent mammograms post 
chemotherapy, preoperative mammogram and on surgical 
specimen. There were no complications associated with 
clip placement such as pain, infection and hemorrhage. 
Out of 25 patients, 17 had Invasive Ductal Carcinoma 
(IDC) grade III, 5 had IDC II, 2 patients of ductal 
carcinoma in situ (DCIS) and 1 patient had metaplastic 
carcinoma grade III. 
The total cost saving for 25 patients was PKR 202,500 
(US$ 2,025). The cost saving for individual patient was 
PKR 81,00 (US$ 81).
Discussion
Neo-adjuvant chemotherapy (NAC) is now a standard 
step in treatment of locally advanced breast cancer when 
it is in early stage. NAC leads frequently to better surgical 
results by conserving the breast or making inoperable 
tumors excisable while lessening complications and 
improving cosmetic outcomes.
At our institution, clip placement prior to NAC is a 
standard procedure because one cannot predict the tumor 
response to NAC. In the past, cases were seen where the 
tumors showed complete radiological response both on 
mammography and ultrasound making localization of 
tumor bed impossible. Therefore, all patients who are to 
receive NAC undergo clip placement and are followed up 
by mammography and subsequent ultrasound to see tumor 
response. Magnetic Resonance Imaging is not performed 
Figure 1. Ultrasound Guided Core Biopsy Needle 
within the Lesion (Arrow)
Figure 2. Craniocaudal View of Right Breast Showing 
Ligaclip within Center of Index Lesion (Arrow)
Figure 3. Craniocaudal View of Right Breast Showing 
Reduction in Size of Index Lesion when Compared 
with Figure 2 (Arrow)
Figure 4. Craniocaudal View of Right Breast Showing 
Bracketing of Ligaclip with three Wires (Arrows)
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routinely because being a third world country, patient 
affordability is a problem as all treatment costs are borne 
by the patients because of lack of health care system by 
government. The commercially available marker clips 
were not available in our institute around 5 years back 
when we started this practice. We, along with breast 
surgery team decided to use surgical ligature clips as an 
alternative to commercially available marker clips. Last 
year we were able to import the commercially available 
marker clips from abroad. These clips were expensive 
so there was a resistance from both the surgeon and 
patients regarding their insertion as they increased the 
cost of treatment further burdening the patient. When the 
patients were given choice of clip types almost all opted 
for surgical clip placement. The surgical clips placed had a 
cost saving of US$ 81 per patient, and overall cost saving 
of US$ 2,025 for 25 patients.  
The study was conducted on hypothesis that surgical 
clips are cost effective, easy to place and are not associated 
with complications of clip migration and hemorrhage.
In our study, all clips were placed under ultrasound 
guidance in the same setting when a core biopsy of index 
lesion was performed. All clips were inserted using a 
16G spinal needle after closing the surgical clip with 
an applicator and placing it into the lesion by using the 
stylet of the spinal needle. The correct clip placement 
was ascertained by ultrasound and doing two views of 
mammogram in orthogonal projections. The clip insertion 
using spinal needle was easy and safe as well as cost 
effective. In a similar study (Lee  at al., 2005; Uematsu 
et al., 2007), the authors placed surgical clip by using 
automated gun for clip placement, but we used a spinal 
needle so we were able to precisely place it in the center 
of lesions , because in automated gun technique the 
placement is dependent on throw of needle. In another 
study (Youn et al., 2015), a semi-automated gun was 
used but in their study, core needle biopsy and clip 
insertion were done in two different sittings, as most of 
their patients had their core needle biopsy performed 
from another hospital. In contrast, we performed core 
needle biopsy of index lesion and any suspicious 
axillary lymph nodes along with clip placement in index 
lesion during the same visit for all patients as it is more 
convenient and a cost and time effective methodology. 
Clip migration can be a limitation of clip insertion 
especially in fatty breasts but the clip is inserted in the 
center of index lesion, thus minimizing clip migration 
due to higher resistance (Margolin  et al., 2003). There 
was no clip migration at the time of clip insertion, post 
chemotherapy and in surgical specimen on mammography 
in all of our patients. The clips allowed easy identification 
of cancer on mammography and helped surgeons in 
explaining the findings to patients. Many studies in 
the past have concluded that placement of radiopaque 
markers are beneficial for tumor localization as well as 
for the assessment of tumor response to NAC, without 
disturbing radiologic evaluation of main lesion (Dash et 
al., 1999; Baron  et al., 2000; Oh  et al., 2007; Genson 
et al., 2007). We were able to evaluate tumor response 
post NAC and localize it with the help of mammography 
as a metallic density and on ultrasound as a small linear 
echogenic structure with or without shadowing. We did 
not perform MRI on our patients due to cost constraints. 
MRI is a better modality for assessing tumor response to 
chemotherapy, this has been reported in several studies 
but the metallic clip produces artifacts in form of signal 
void depending upon magnetic susceptibility, clip quality, 
size, shape, orientation, position and parameters used for 
MRI examination (Genson  et al., 2007).
There are a few limitations of this study. The sample 
size was 25, however with 25 patients in this study we 
still can conclude that there was significant cost saving 
per patient if we consider cost constraints for a self-paying 
patient in a third world country. The results for clip 
migration and complications cannot be generalized due 
to small sample; studies with larger sample size should be 
conducted to generalize the results on larger population 
groups. Another limitation is non-conductance of MR 
examination to see tumor response in our patients again 
because of cost constraints on patients. However we have 
evaluated tumor response to NAC by mammography 
and ultrasound and have obtained almost similar results 
to studies using mammography, ultrasound and MRI. 
However, in a study by (Genson  et al., 2007), it is reported 
that artifacts caused by tissue marker clips can limit the 
sensitivity of MRI for detection and follow up of breast 
cancer.
In conclusion, we concluded from this study that 
ligaclip placement in patients with breast cancer 
Figure 5. Craniocaudal View of Left Breast Showing 
Needle Localization of Ligaclip Prior to Excisional 
Biopsy (Black arrow =ligaclip, White arrow =localizing 
wire)
Figure 6. Magnified View of Excised Specimen Showing 
Ligaclip and Localizing Wire (Black arrow=Ligaclip, 
White arrow= localizing wire)
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undergoing NAC is a cost effective method for following 
response to NAC and is helpful in further surgical 
management post NAC. It is not associated with clip 
migration or significant complications related to clip 
placement but larger studies are needed to generalize 
our results.
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